Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.

about

Soluble interleukin 23 receptor gene therapy with adeno-associated vectors for the treatment of multiple sclerosis.Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.

P2860

Q45840225-A255781D-13DE-4D19-931C-AAA6FD36C73B Q55052878-9DD7D484-A711-4E88-8E1C-46AC7F86DC5C

P2860

Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.

Item

http://www.wikidata.org/entity/Q40167890

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Clinical and Histopathological ...... luble Interleukin-23 Receptor.

@en

type

Item

label

Clinical and Histopathological ...... luble Interleukin-23 Receptor.

@en

prefLabel

Clinical and Histopathological ...... luble Interleukin-23 Receptor.

@en

P1476

Clinical and Histopathological ...... oluble Interleukin-23 Receptor

@en

P2093

A Raul Castaño

http://www.w3.org/2001/XMLSchema#string

Gitta Stockinger

http://www.w3.org/2001/XMLSchema#string

Marcos Tejero

http://www.w3.org/2001/XMLSchema#string

Marta Miralles

http://www.w3.org/2001/XMLSchema#string

Meritxell Puig

http://www.w3.org/2001/XMLSchema#string

Miguel Chillon

http://www.w3.org/2001/XMLSchema#string

P2860

IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production

Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

STAT3 regulates cytokine-mediated generation of inflammatory helper T cells

Identification and expression analysis of alternatively spliced isoforms of human interleukin-23 receptor gene in normal lymphoid cells and selected tumor cells

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

Anti-interleukin-12 antibody for active Crohn's disease

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

P2888

s13311-017-0545-8

P304

1095-1106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13311-017-0545-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28593439

http://www.w3.org/2001/XMLSchema#string

P932

5722756

http://www.w3.org/2001/XMLSchema#string

Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.

about

P2860

P2860

Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P932